Navigation Links
Bowel Cancer Drug Campaigner Dies After Surgery

Hayley Newbery, the 26-year-old mother-of-three who ignited a national newspaper campaign in order to procure an unapproved drug to treat bowel cancer, has died at the St James's Hospital in Leeds.// Mrs Newbery could not tolerate surgery to remove liver and bowel tumors.

Doctors told Mrs Newbery last year that she had only two months to live unless she took Avastin to reduce the size of the tumors. A hospital spokesman said she had died after a 10 and half hour operation. "I am able to confirm she has sadly died. Of course our thoughts are with her family at this time," he said, adding that the family had asked not to reveal any details. The hospital also said that the first part of the surgery on the bowel went well, but complications arose after the liver surgery.

Avastin is available for £50,000 in private, but Mrs Newbery was given the drug after the Daily Mirror newspaper launched a campaign to procure the drug from NHS. Just before she went in for surgery Mrs Newbery was shown on television when she said that she knew the risks of the operation, but wanted to go through it for the sake of her children. Her husband Christian and father Roger were at her bedside throughout.
'"/>




Page: 1

Related medicine news :

1. Bowel diseases linked to bug in milk
2. Hope For Patients With Inflammatory Bowel Disease
3. Cannabinoids - Antidepressant And Inflammatory Bowel Disease Treatment
4. Eating Red and Processed Meat may cause Bowel cancer
5. Just Had Bowel Surgery? Chew Gum For A Speedy Recovery
6. Delay In Life-Saving Bowel Cancer Screening Programme In UK
7. National Bowel Cancer Screening Programme Lauded
8. New compounds Help Sustain relief For Patients With Symptoms of Bowel Disorders
9. Parasitic Worms Could Be Used To Treat Bowel Disease
10. Inflammatory Bowel Diseases Cured By Parasitic Worms
11. Analysis: Bowel Diseases Triples Infertility Risks In Women
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root ... Orleans. This is a new, greatly improved version of the Doctor Referral teaming dataset ... by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released by ...
(Date:6/24/2017)... York (PRWEB) , ... June 24, 2017 , ... ... the Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers ... evenings and weekends so that visits to the dentist fit into their patients’ ...
(Date:6/23/2017)... ... 23, 2017 , ... By scoring 100% for fiscal management and accountability, the ... online charity evaluator, Charity Navigator, validating ANRF's work as a top charity in America. ... Charity Navigator and earns ANRF a spot on their “ 10 Charities Worth Watching ...
(Date:6/23/2017)... ... 2017 , ... Military Connection friend and veteran advocate Micaela Bensko ... Atlantic lounge. , Bensko is no stranger to the plight of the disabled. ... life to supporting our wounded veterans. A world-class photographer, her riveting photos “The Wounds ...
(Date:6/23/2017)... ... 2017 , ... Georgia State University will host the First ... two-day conference is focused on advancing scientific knowledge about the aggressive triple negative ... racial breast cancer-related disparities. The conference theme is “Illuminating Actionable Biology.” , Conference ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: